Skip to content
Abierto
Menu

Special notice, total small business set-aside, first published as award notice

Award Notice Correction: SAGENT - CIPROFLOXACIN 400 MG/200ML-D5W - BASE+4

36C77026P0086

Department of Veterans Affairs, National Cmop Office. Pharmaceutical Preparation Manufacturing.

View on SAM.govMarkdown

Awarded

Sagent Pharmaceuticals, Inc.

$275,580.00 obligated so far on USAspending

Description

As published on SAM.gov.

This Special Notice is to correct SAGENT - CIPROFLOXACIN 400 MG/200ML-D5W - BASE+4 total contract amount to include Base + 4 Option Years.

Base: $275,580.00 Base w/ OY's: $1,377,900.00

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Sagent Pharmaceuticals, Inc.
UEI
PR1HCLM3FMW7
CAGE
4RP13
Vendor location
Schaumburg, IL
Contract
36C77026P0086, purchase order
Obligated
$275,580.00, potential $1,337,900
Actions
1 between August 11, 2026 and August 11, 2026
Competition
Competed Under SAP, 6 offers received
Set-aside reported
No Set Aside Used.
Described as
Ciprofloxaxin Ivpb
Match
solicitation number 36C77026P0086 was reused as the contract number; same awarding office 36C770 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 11, 2026

    Award notice

    SAGENT - CIPROFLOXACIN 400 MG/200ML-D5W - BASE+4

    Awarded to Sagent Pharmaceuticals, Inc. Schaumburg 60173 for $275,580. SAM.gov, notice 6211b7dd72a547fa91bc7bcde8542e2d

  2. August 11, 2026

    Special notice, originally award notice

    Due August 11, 2026 at 4:00 PM EDT. SAM.gov, notice e7ceaff242624f73a40f7cc3abc1d11a

Points of contact

Also open from this buyer